Prabir Roy-Chaudhury, MD, PhD, Division Chief
Allon M, Brouwer-Maier DJ, Abreo K, Baskin KM, Bregel K, Chand DH, Easom AM, Mermel L, Mokrzycki MH, Patel PR, Roy-Chaudhury P, Shenoy S, Valentini RP, Wasse H. Recommended Clinical Trial End Points for Dialysis Catheters. Clin J Am Soc Nephrol 2018;13:495-500.
Allon M, Imrey PB, Cheung AK, Radeva M, Alpers CE, Beck GJ, Dember LM, Farber A, Greene T, Himmelfarb J, Huber TS, Kaufman JS, Kusek JW, Roy-Chaudhury P, Robbin ML, Vazquez MA, Feldman HI; Hemodialysis Fistula Maturation (HFM) Study Group. Relationships Between Clinical Processes and Arteriovenous Fistula Cannulation and Maturation: A Multicenter Prospective Cohort Study. Am J Kidney Dis 2018;71:677-89.
Alpers CE, Imrey PB, Hudkins KL, Wietecha TA, Radeva M, Allon M, Cheung AK, Dember LM, Roy-Chaudhury P, Shiu YT, Terry CM, Farber A, Beck GJ, Feldman HI, Kusek JW, Himmelfarb J; Hemodialysis Fistula Maturation Study Group. Histopathology of Veins Obtained at Hemodialysis Arteriovenous Fistula Creation Surgery. J Am Soc Nephrol 2017;28:3076-88.
Beathard GA, Lok CE, Glickman MH, Al-Jaishi AA, Bednarski D, Cull DL, Lawson JH, Lee TC, Niyyar VD, Syracuse D, Trerotola SO, Roy-Chaudhury P, Shenoy S, Underwood M, Wasse H, Woo K, Yuo TH, Huber TS. Definitions and End Points for Interventional Studies for Arteriovenous Dialysis Access. Clin J Am Soc Nephrol 2018;13:501-12.
Buszek SM, Roy-chaudhury P, Yadlapalli G. Olanzapine-Induced Hypertriglyceridemia Resulting in Necrotizing Pancreatitis. ACG Case Rep J. 2016;3(4):e104.
Charytan DM, Roy-Chaudhury P. The Authors Reply. Kidney Int 2018;94:430-1.
Cheung AK, Imrey PB, Alpers CE, Robbin ML, Radeva M, Larive B, Shiu YT, Allon M, Dember LM, Greene T, Himmelfarb J, Roy-Chaudhury P, Terry CM, Vazquez MA, Kusek JW, Feldman HI; Hemodialysis Fistula Maturation Study Group. Intimal Hyperplasia, Stenosis, and Arteriovenous Fistula Maturation Failure in the Hemodialysis Fistula Maturation Study. J Am Soc Nephrol 2017;28:3005-13.
Chitalia N, Ross L, Krishnamoorthy M, et al. Neointimal hyperplasia and calcification in medium sized arteries in adult patients with chronic kidney disease. Semin Dial. 2015;28(3):E35-40.
Dember LM, Imrey PB, Duess MA, et al. Vascular Function at Baseline in the Hemodialysis Fistula Maturation Study. J Am Heart Assoc. 2016;5(7)
Epstein M, Roy-Chaudhury P. Arrhythmias and sudden cardiac death in hemodialysis patients. Temporal profile, electrolyte abnormalities, and potential targeted therapies. Nephrol News Issues. 2016;30(4):suppl 23-6.
Glickman MH, Burgess J, Cull D, Roy-Chaudhury P, Schanzer H. Prospective multicenter study with a 1-year analysis of a new vascular graft used for early cannulation in patients undergoing hemodialysis. J Vasc Surg. 2015;62(2):434-41.
He Y, Shiu YT, Pike DB, Roy-Chaudhury P, Cheung AK, Berceli SA. Comparison of hemodialysis arteriovenous fistula blood flow rates measured by Doppler ultrasound and phase-contrast magnetic resonance imaging. J Vasc Surg 2018.
Liang M, Wang Y, Liang A, et al. Migration of smooth muscle cells from the arterial anastomosis of arteriovenous fistulas requires Notch activation to form neointima. Kidney Int. 2015;88(3):490-502.
Linde PG, Archdeacon P, Breyer MD, et al. Overcoming Barriers in Kidney Health-Forging a Platform for Innovation. J Am Soc Nephrol. 2016;27(7):1902-10.
Nikam M, Chemla ES, Evans J, et al. Prospective controlled pilot study of arteriovenous fistula placement using the novel Optiflow device. J Vasc Surg. 2015;61(4):1020-5.
Roy-Chaudhury P. Exploring Novel Endpoints for Clinical Trials in Kidney Disease: Challenges and Opportunities. Kidney Int Rep 2017;2:295-6.
Roy-Chaudhury P, Tumlin JA, Koplan BA, Costea AI, Kher V, Williamson D, Pokhariyal S, Charytan DM; MiD investigators and committees. Primary outcomes of the Monitoring in Dialysis Study indicate that clinically significant arrhythmias are common in hemodialysis patients and related to dialytic cycle. Kidney Int 2018;93:941-51.
Roy-Chaudhury P. Pragmatic, Precision Medicine Approaches for Dialysis Vascular Access Dysfunction: Challenges and Opportunities. Clin J Am Soc Nephrol. 2016;11(9):1525-6.
Roy-Chaudhury P, Kruska L. Future directions for vascular access for hemodialysis. Semin Dial. 2015;28(2):107-13.
Saum K, Campos B, Celdran-Bonafonte D, Nayak L, Sangwung P, Thakar C, Roy-Chaudhury P, Owens AP Iii PhD. Uremic Advanced Glycation End Products and Protein-Bound Solutes Induce Endothelial Dysfunction Through Suppression of Kruppel-Like Factor 2. J Am Heart Assoc 2018;7.
Shenoy S, Allon M, Beathard G, Brouwer-Maier D, Dember LM, Glickman M, Lee C, Litchfield T, Lok C, Huber T, Roy-Chaudhury P, Work J, West M, Wasse H. Clinical Trial End Points for Hemodialysis Vascular Access: Background, Rationale, and Definitions. Clin J Am Soc Nephrol 2018;13:490-4.
Trerotola SO, Lawson J, Roy-Chaudhury P, Saad TF, Lutonix AVCTI. Drug Coated Balloon Angioplasty in Failing AV Fistulas: A Randomized Controlled Trial. Clin J Am Soc Nephrol 2018;13:1215-24.
van Ballegooijen AJ, Zelnick L, Hoofnagle AN, Hamburg NM, Robinson-Cohen C, Roy-Chaudhury P, Cheung AK, Shiu YT, de Boer IH, Himmelfarb J, Beck G, Imrey PB, Kusek JW, Kestenbaum B; Hemodialysis Fistula Maturation (HFM) Study Group. Association of Vitamin D Metabolites With Arterial Function in the Hemodialysis Fistula Maturation Study. Am J Kidney Dis 2017;69:805-14.
V Viecelli AK, Mori TA, Roy-Chaudhury P, Polkinghorne KR, Hawley CM, Johnson DW, Pascoe EM, Irish AB. The pathogenesis of hemodialysis vascular access failure and systemic therapies for its prevention: Optimism unfulfilled. Semin Dial 2018;31:244-57.
Wang K1, Zelnick LR, Imrey PB, deBoer IH, Himmelfarb J, Allon MD, Cheung AK, Dember LM, Roy-Chaudhury P, Vazquez MA, Kusek JW, Feldman HI, Beck GJ, Kestenbaum B; the Hemodialysis Fistula Maturation Study Group. Effect of Anti-Hypertensive Medication History on Arteriovenous Fistula Maturation Outcomes. Am J Nephrol 2018;48:56-64.
Wong CY, De vries MR, Wang Y, et al. A Novel Murine Model of Arteriovenous Fistula Failure: The Surgical Procedure in Detail. J Vis Exp. 2016;(108):e53294.
Sas KM, Lin J, Rajendiran TM, Soni T, Nair V, Hinder LM, Jagadish HV, Gardner TW, Abcouwer SF, Brosius FC 3rd, Feldman EL, Kretzler M, Michailidis G, Pennathur S. Shared and distinct lipid-lipid interactions in plasma and affected tissues in a diabetic mouse model. J Lipid Res. J Lipid Res. 2018 Feb;59(2):173-183.
Tuttle KR, Brosius FC 3rd*, Adler SG, Kretzler M, Mehta RL, Tumlin JA, Tanaka Y, Haneda M, Liu J, Silk ME, Cardillo TE, Duffin KL, Haas JV, Macias WL, Nunes FP, Janes JM. JAK1/JAK2 Inhibition by Baricitinib in Diabetic Kidney Disease: Results from a Phase 2 Randomized Controlled Clinical Trial (*co-first and co-corresponding author), Nephrol Dial Transplant. 2018; Feb 22. doi: 10.1093/ndt/gfx377. [Epub ahead of print]
Brosius FC, Jun W. The Promise of System Biology for Diabetic Kidney Disease. Adv Chronic Kidney Dis. 2018;25(2):202-213
Mathew A, Atkins K, Brosius FC, Pennathur S. Myeloperoxidase Derived Oxidants Damage Artery Wall Proteins in an Animal Model of Chronic Kidney Disease Accelerated Atherosclerosis. J Biol Chem. 2018;11;293(19):7238-7249
Tuegel C, Katz R, Alam M, Bhat Z, Bellovich K, de Boer I, Brosius F, Gadegbeku C, Gipson D, Hawkins J, Himmelfarb J, Ju W, Kestenbaum B, Kretzler M, Robinson-Cohen C, Steigerwalt S, Bansal N. Growth differentiation factor-15, Galectin-3, and Soluble ST-2 and Risk of Mortality and Cardiovascular Events in Chronic Kidney Disease. Am J Kidney Dis, 2018; pii: S0272-6386(18)30636-X. doi: 10.1053/j.ajkd.2018.03.025. [Epub ahead of print]
Bakhtar O, Thajudeen B, Sussman A. Decreasing After-Hours Hemodialysis in Hospitals. Ther Apher Dial. 2016;20(1):87-8.
Howlader A, Thajudeen B, Sussman AN, Bracamonte E, Krahl L, Nasr SH. Proliferative Glomerulonephritis With Masked Monoclonal Deposits Responsive to Myeloma Therapy. Kidney Int Rep. 2017;2(6):1233-1237.
Kaur G, Thajudeen B. Asymptomatic bilateral giant angiomyolipoma. Saudi J Kidney Dis Transpl. 2017;28(3):675-677.
Kaur G, Bijin B, Saleem K, Sarsah B, Thajudeen B. Leukocyte Cell-Derived Chemotaxin 2-Associated Renal Amyloidosis: A Case Report. Case Rep Nephrol Dial. 2017;7(2):121-129.
Moinuddin I, Thajudeen B, Sussman A, et al. Early Posttransplant Isolated v1 Lesion Does Not Need to Be Treated and Does Not Lead to Increased Fibrosis. Case Rep Transplant. 2016;2016:4603014.
Moinuddin I, Madhrira M, Bracamonte E, Thajudeen B, Sussman A. Membranous nephropathy with crescents associated with levamisole-induced MPO-ANCA vasculitis. Pathol Res Pract. 2016;212(7):650-3.
Murugapandian S, Mansour I, Hudeeb M, et al. Epidemiology of Glomerular Disease in Southern Arizona: Review of 10-Year Renal Biopsy Data. Medicine (Baltimore). 2016;95(18):e3633.
Sardar A, Thajudeen B, Kadambi PV. Histoplasma Peritonitis: An Extremely Rare Complication of Peritoneal Dialysis.Case Rep Nephrol. 2018 May 10;2018:8015230. doi: 10.1155/2018/8015230. PMID 29862101\
Thajudeen B, Salahudeen AK. Role of tolvaptan in the management of hyponatremia in patients with lung and other cancers: current data and future perspectives. Cancer Manag Res. 2016;8:105-14.
Cedillo-Couvert EA, Ricardo AC, Chen J, Cohan J, Fischer MJ, Krousel-Wood M, Kusek JW, Lederer S, Lustigova E, Ojo A, Porter AC, Sharp LK, Sondheimer J, Diamantidis C, Wang X, Roy J, Lash JP; CRIC Study Investigators. Self-reported Medication Adherence and CKD Progression. Kidney Int Rep. 2018;3(3):645-651.
Mathur AK, Xing J, Dickinson DM, Warren PH, Gifford KA, Hong BA, Ojo A, Merion RM. Return on investment for financial assistance for living kidney donors in the United States. Clin Transplant. 2018;32(7):e13277.
Adeoye AM, Tayo BO, Owolabi MO, Adebiyi AA, Lackland DT, Cooper R, Ojo A, Ogedegbe G. Ambulatory blood pressure threshold for black Africans: more questions than answers. J Clin Hypertens (Greenwich). 2018;20(5):847-849.
Howlader A, Thajudeen B, Sussman AN, Bracamonte E, Krahl L, Nasr SH. Proliferative Glomerulonephritis With Masked Monoclonal Deposits Responsive to Myeloma Therapy. Kidney Int Rep. 2017;2(6):1233-1237.
Moinuddin I, Thajudeen B, Sussman A, et al. Early Posttransplant Isolated v1 Lesion Does Not Need to Be Treated and Does Not Lead to Increased Fibrosis. Case Rep Transplant. 2016;2016:4603014.
Moinuddin I, Madhrira M, Bracamonte E, Thajudeen B, Sussman A. Membranous nephropathy with crescents associated with levamisole-induced MPO-ANCA vasculitis. Pathol Res Pract. 2016;212(7):650-3.
Bakhtar O, Thajudeen B, Sussman A. Decreasing After-Hours Hemodialysis in Hospitals. Ther Apher Dial. 2016;20(1):87-8.
Tiu H, Fagerlin A, Roney M, et al. Provider perspectives on chronic kidney disease diagnosis delivery . Clin Nephrol. 2018;89(3):205-213.
Murugapandian S, Mansour I, Hudeeb M, et al. Epidemiology of Glomerular Disease in Southern Arizona: Review of 10-Year Renal Biopsy Data. Medicine (Baltimore). 2016;95(18):e3633.
Murugapandian S, Bijin B, Mansour I, et al. Improvement in Gemcitabine-Induced Thrombotic Microangiopathy with Rituximab in a Patient with Ovarian Cancer: Mechanistic Considerations. Case Rep Nephrol Dial. 2015;5(2):160-7.
Shanmugasundaram M, Murugapandian S, Truong HT, Lotun K, Banerjee S. Drug coated balloon in peripheral artery disease. Cardiovasc Revasc Med. 2018;
Brooks HL, Lindsey ML. Guidelines for authors and reviewers on antibody use in physiology studies. Am J Physiol Heart Circ Physiol. 2018;314(4):H724-H732.
Irsik DL, Romero-Aleshire MJ, Chavez EM, Fallet RW, Brooks HL, Carmines PK, Lane PH. Renoprotective impact of estrogen receptor-α and its splice variants in female mice with type 1 diabetes. Am J Physiol Renal Physiol. 2018;315(3):F512-F520.
Small DM, Sanchez WY, Roy SF, Morais C, Brooks HL, Coombes JS, Johnson DW, Gobe GC. N-acetyl-cysteine increases cellular dysfunction in progressive chronic kidney damage after acute kidney injury by dampening endogenous antioxidant responses. Am J Physiol Renal Physiol. 2018;314(5):F956-F968.
Poulsen SB, Kristensen TB, Brooks HL, Kohan DE, Rieg T, Fenton RA. Role of adenylyl cyclase 6 in the development of lithium-induced nephrogenic diabetes insipidus. JCI Insight. 2017;2(7):e91042.
Bhargava P, Schnellmann RG. Mitochondrial energetics in the kidney. Nat Rev Nephrol. 2017;13(10):629-646.
Cameron RB, Beeson CC, Schnellmann RG. Development of Therapeutics That Induce Mitochondrial Biogenesis for the Treatment of Acute and Chronic Degenerative Diseases. J Med Chem. 2016;59(23):10411-10434.
Cameron RB, Beeson CC, Schnellmann RG. Structural and pharmacological basis for the induction of mitochondrial biogenesis by formoterol but not clenbuterol. Sci Rep. 2017;7(1):10578.
Collier JB, Schnellmann RG. Extracellular Signal-Regulated Kinase 1/2 Regulates Kidney Injury Molecule-1 Expression Physiologically and Following Ischemic and Septic Renal Injury. J Pharmacol Exp Ther. 2017;
Collier JB, Whitaker RM, Eblen ST, Schnellmann RG. Rapid Renal Regulation of Peroxisome Proliferator-activated Receptor γ Coactivator-1α by Extracellular Signal-Regulated Kinase 1/2 in Physiological and Pathological Conditions. J Biol Chem. 2016;291(52):26850-26859.
Dupre TV, Doll MA, Shah PP, et al. Inhibiting glucosylceramide synthase exacerbates cisplatin-induced acute kidney injury. J Lipid Res. 2017;58(7):1439-1452.
Dupre TV, Doll MA, Shah PP, et al. Suramin protects from cisplatin-induced acute kidney injury. Am J Physiol Renal Physiol. 2016;310(3):F248-58.
Gibbs WS, Collier JB, Morris M, Beeson CC, Megyesi J, Schnellmann RG. 5-HT receptor regulates mitochondrial homeostasis and its loss potentiates acute kidney injury and impairs renal recovery. Am J Physiol Renal Physiol. 2018;315(4):F1119-F1128.
Gibbs WS, Garrett SM, Beeson CC, Schnellmann RG. Identification of dual mechanisms mediating 5-hydroxytryptamine receptor 1F-induced mitochondrial biogenesis. Am J Physiol Renal Physiol. 2018;314(2):F260-F268.
Gibbs WS, Weber RA, Schnellmann RG, Adkins DL. Disrupted mitochondrial genes and inflammation following stroke. Life Sci. 2016;166:139-148.
Krishnasamy Y, Ramshesh VK, Gooz M, Schnellmann RG, Lemasters JJ, Zhong Z. Ethanol and High Cholesterol Diet Causes Severe Steatohepatitis and Early Liver Fibrosis in Mice. PLoS ONE. 2016;11(9):e0163342.
Harmon JL, Gibbs WS, Whitaker RM, Schnellmann RG, Adkins DL. Striatal Mitochondrial Disruption following Severe Traumatic Brain Injury. J Neurotrauma. 2017;34(2):487-494.
Harmon JL, Wills LP, Mcomish CE, et al. 5-HT2 Receptor Regulation of Mitochondrial Genes: Unexpected Pharmacological Effects of Agonists and Antagonists. J Pharmacol Exp Ther. 2016;357(1):1-9.
Rehman H, Liu Q, Krishnasamy Y, et al. The mitochondria-targeted antioxidant MitoQ attenuates liver fibrosis in mice. Int J Physiol Pathophysiol Pharmacol. 2016;8(1):14-27.
Schnellmann R. Resistin Resets Neutrophil Function in Kidney Diseases. Crit Care Med. 2016;44(7):1454-5.
Scholpa NE, Williams H, Wang W, et al. Pharmacological stimulation of mitochondrial biogenesis using the FDA-approved β<sub>2</sub>-adrenoreceptor agonist formoterol for the treatment of spinal cord injury. J Neurotrauma. 2018;
Scholpa NE, Lynn MK, Corum D, Boger HA, Schnellmann RG. 5-HT receptor-mediated mitochondrial biogenesis for the treatment of Parkinson's disease. Br J Pharmacol. 2018;175(2):348-358.
Scholpa NE, Schnellmann RG. Mitochondrial-Based Therapeutics for the Treatment of Spinal Cord Injury: Mitochondrial Biogenesis as a Potential Pharmacological Target. J Pharmacol Exp Ther. 2017;363(3):303-313.
Smith JA, Mayeux PR, Schnellmann RG. Delayed Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Inhibition by Trametinib Attenuates Systemic Inflammatory Responses and Multiple Organ Injury in Murine Sepsis. Crit Care Med. 2016;44(8):e711-20.
Whitaker RM, Corum D, Beeson CC, Schnellmann RG. Mitochondrial Biogenesis as a Pharmacological Target: A New Approach to Acute and Chronic Diseases. Annu Rev Pharmacol Toxicol. 2016;56:229-49.
2016-2017 Publications
Nair V, Robinson-Cohen C, Smith MR, Bellovich KA, Bhat ZY, Bobadilla M, Brosius F, de Boer IH, Essioux L, Formentini I, Gadegbeku CA, Gipson D, Hawkins J, Himmelfarb J, Kestenbaum B, Kretzler M, Magnone MC, Perumal K, Steigerwalt S, Ju W, Bansal N. J. Growth Differentiation Factor-15 and Risk of CKD Progression. J Am Soc Nephrol. 2017 July;28(7):2233-2240.
Zhang H, Nair V, Saha J, Atkins KB, Hodgin JB, Saunders TL, Myers MG Jr, Werner T, Kretzler M, Brosius FC. Podocyte-specific JAK2 Overexpression Worsens Diabetic Kidney Disease in Mice. Kidney International, 2017 May 26.
Dupre TV, Doll MA, Shah PP, Sharp CN, Siow D, Megyesi J, Shayman J, Bielawska A, Bielawski J, Beverly LJ, Hernandez-Corbacho M, Clarke CJ, Snider AJ, Schnellmann RG, Obeid LM, Hannun YA, Siskind LJ. Inhibiting glucosylceramide synthase exacerbates cisplatin-induced acute kidney injury. J Lipid Res. 2017 Jul;58(7):1439-1452. doi: 10.1194/jlr.M076745. Epub 2017 May 10.
van Ballegooijen AJ, Zelnick L, Hoofnagle AN, Hamburg NM, Robinson-Cohen C, Roy-Chaudhury P, Cheung AK, Shiu YT, de Boer IH, Himmelfarb J, Beck G, Imrey PB, Kusek JW, Kestenbaum B; Hemodialysis Fistula Maturation (HFM) Study Group. Association of Vitamin D Metabolites With Arterial Function in the Hemodialysis Fistula Maturation Study. Am J Kidney Dis. 2017 Jun;69(6):805-814. doi: 10.1053/j.ajkd.2017.01.049. Epub 2017 Mar 27. PMID: 28359657
O'Brien PD, Hinder LM, Parlee SD, Hayes JM, Backus C, Zhang H, Ma L, Sakowski SA, Brosius FC 3rd, Feldman EL. Dual CCR2/CCR5 antagonist treatment attenuates adipose inflammation, but not microvascular complications in ob/ob mice. Diabetes Obes Metab. 2017 Mar 23. [Epub ahead of print].
Park M, Rumora AE, Hinder LM, Hur J, Eichinger F, Pennathur S, Kretzler M, Brosius FC 3rd, Feldman EL. Comparative RNA-Seq Transcriptome Analyses Reveal Distinct Metabolic Pathways in Diabetic Nerve and Kidney Disease. J Cell Mol Med, 2017 Mar 8.
Kohler LN, et al. Greater Adherence to Cancer Prevention Guidelines Is Associated with Higher Circulating Concentrations of Vitamin D Metabolites in a Cross-Sectional Analysis of Pooled Participants from 2 Chemoprevention Trials. J Nutr. 2017 Mar;147(3):421-429. doi: 10.3945/jn.116.243352. Epub 2017 Jan 25. PMID: 28122932
Janda J, Burkett NB, Blohm-Mangone K, Huang V, Curiel-Lewandrowski C, Alberts DS, Petricoin EF 3rd, Calvert VS, Einspahr J, Dong Z, Bode AM, Wondrak GT, Dickinson SE. Resatorvid-based Pharmacological Antagonism of Cutaneous TLR4 Blocks UV-induced NF-κB and AP-1 Signaling in Keratinocytes and Mouse Skin. Photochem Photobiol. 2016 Nov;92(6):816-825. doi: 10.1111/php.12659. Epub 2016 Dec 8. PMID: 27859308
Collier JB, Whitaker RM, Eblen ST, Schnellmann RG. Rapid Renal Regulation of Peroxisome Proliferator-activated Receptor γ Coactivator-1α by Extracellular Signal-Regulated Kinase 1/2 in Physiological and Pathological Conditions. J Biol Chem. 2016 Dec 23;291(52):26850-26859. doi: 10.1074/jbc.M116.754762. Epub 2016 Nov 14.
Gibbs WS, Weber RA, Schnellmann RG, Adkins DL. Disrupted mitochondrial genes and inflammation following stroke. Life Sci. 2016 Dec 1;166:139-148. doi: 10.1016/j.lfs.2016.09.021. Epub 2016 Sep 28.
Krishnasamy Y, Ramshesh VK, Gooz M, Schnellmann RG, Lemasters JJ, Zhong Z. Ethanol and High Cholesterol Diet Causes Severe Steatohepatitis and Early Liver Fibrosis in Mice. PLoS One. 2016 Sep 27;11(9):e0163342. doi: 10.1371/journal.pone.0163342. eCollection 2016.
Siddiqui B, Greka A, Popovtzer M, Rennke HG, Jeselsohn R. Immune Complex-Mediated Proliferative Glomerulonephritis Induced by Paclitaxel Treatment. J Oncol Pract 2016 Dec 12(12): 1272-1274.
Cameron RB, Beeson CC, Schnellmann RG. Development of Therapeutics That Induce Mitochondrial Biogenesis for the Treatment of Acute and Chronic Degenerative Diseases. J Med Chem. 2016 Dec 8;59(23):10411-10434. Epub 2016 Sep 27. Review.
Roy-Chaudhury P. Dialysis: Bioengineered vessels for dialysis access: soon to be a reality? Nat Rev Nephrol. 2016 Sep;12(9):516-7. doi: 10.1038/nrneph.2016.119. Epub 2016 Aug 1. PMID: 27477493
Harmon JL, Gibbs WS, Whitaker RM, Schnellmann RG, Adkins DL. Striatal Mitochondrial Disruption following Severe Traumatic Brain Injury. J Neurotrauma. 2017 Jan 15;34(2):487-494. doi: 10.1089/neu.2015.4395. Epub 2016 Aug 1.
Roy-Chaudhury P. Pragmatic, Precision Medicine Approaches for Dialysis Vascular Access Dysfunction: Challenges and Opportunities. Clin J Am Soc Nephrol. 2016 Sep 7;11(9):1525-6. doi: 10.2215/CJN.08160816. Epub 2016 Aug 30. PMID: 27577242
Murugapandian S, Mansour I, Hudeeb M, Hamed K, Hammode E, Bijin B, Daheshpour S, Thajudeen B, Kadambi P. Epidemiology of Glomerular Disease in Southern Arizona: Review of 10-Year Renal Biopsy Data. Medicine (Baltimore). 2016 May;95(18):e3633. doi: 10.1097/MD.0000000000003633. PMID: 27149502
Janda J, Nfonsam V, Calienes F, Sligh JE, Jandova J. Modulation of ROS levels in fibroblasts by altering mitochondria regulates the process of wound healing. Arch Dermatol Res. 2016 May;308(4):239-48. doi: 10.1007/s00403-016-1628-9. Epub 2016 Feb 12. PMID: 26873374